Alpha Med Physicians Group Radiation Oncology Helps Pioneer Use of Elekta’s Beam Shaping Innovation for Radiation Therapy of Cancer
Chicago-based Alpha Med Physicians Group (AMPG) Radiation Oncology, located in the Alpha Med Center, 17333 S. LaGrange Road, Tinley Park, IL, recently began using Elekta’s Agility™ 160-leaf multi-leaf collimator (MLC) in radiation therapy treatments for its patients with cancer. According to AMPG Radiation Oncology clinicians, Agility offers several advantages that directly benefit their patients with cancer.
Significant progress has been made in the delivery of Radiation Therapy treatments, which has enabled us to decrease the side effects related to radiation and deliver higher cancer killing doses of radiation, Syed Javed Shirazi, M.D.
Agility is a 160-leaf multi-leaf collimator (MLC) that shapes the beams of radiation delivered by the treatment system before they reach the tumor target in the patient. Developed by Elekta, a global leader pioneering significant innovations and clinical solutions for treating cancer and brain disorders, Agility represents a radical reinvention of MLC beam shaping technology, providing much faster beam shaping (for quicker treatments) and greater precision (reducing unwanted dose to organs at risk).
This equipment will enable us to provide stereotactic radiation treatments (localized radiation). Thereby, allowing us to treat patients in a shorter length of time. We can now treat patients in 1-5 treatments to certain sites instead of traditional 20-35 treatments, Neil Mehta, M.D.
All members of AMPG Radiation Oncology are Board Certified Radiation Oncologists, specializing in the diagnosis, treatment, and longer-term care of patients with cancer. AMPG Radiation Oncology group physicians have received their specialty education at some of the country’s most prestigious medical institutions, including Rush Medical Center, the University of Chicago and Northwestern Memorial Hospital of Chicago. In addition, AMPG Radiation Oncology has experience in treating all major cancer diagnoses including breast, head and neck, lung, gastro-intestinal, colon, rectal, Hodgkin’s disease, lymphoma, prostate, skin, brain, uterine, other malignancies, and benign conditions.
More about Agility
Agility enables the physician to tailor therapeutic radiation beams that are directed to the patient’s tumor. External beam radiation is delivered by a device called a linear accelerator, also known as a linac. The head of the linac holds Agility, a multi-leaf collimator (MLC) that employs 160 moving tungsten leaves, which block portions of the radiation beam to shape it as it exits the device. The more the beam shape conforms to the tumor shape, the more accurately it targets the tumor. Greater targeting accuracy reduces the potential for damage to surrounding tissues, thereby decreasing the risk of side effects.